Cerebrospinal fluid β-glucocerebrosidase activity is reduced in parkinson's disease patients
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cerebrospinal fluid β-glucocerebrosidase activity is reduced in parkinson's disease patients
Authors
Keywords
-
Journal
MOVEMENT DISORDERS
Volume 32, Issue 10, Pages 1423-1431
Publisher
Wiley
Online
2017-08-26
DOI
10.1002/mds.27136
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's
- (2016) Ganqiang Liu et al. ANNALS OF NEUROLOGY
- Survival and dementia inGBA-associated Parkinson's disease: The mutation matters
- (2016) Roberto Cilia et al. ANNALS OF NEUROLOGY
- Glucocerebrosidase in Parkinson's disease: Insights into pathogenesis and prospects for treatment
- (2016) Anthony H.V. Schapira et al. MOVEMENT DISORDERS
- The BioFIND study: Characteristics of a clinically typical Parkinson's disease biomarker cohort
- (2016) Un Jung Kang et al. MOVEMENT DISORDERS
- Mannose 6-Phosphate Receptor Is Reduced in -Synuclein Overexpressing Models of Parkinsons Disease
- (2016) Carmela Matrone et al. PLoS One
- Association ofGBAMutations and the E326K Polymorphism With Motor and Cognitive Progression in Parkinson Disease
- (2016) Marie Y. Davis et al. JAMA Neurology
- Selective loss of glucocerebrosidase activity in sporadic Parkinson’s disease and dementia with Lewy bodies
- (2015) Davide Chiasserini et al. Molecular Neurodegeneration
- Haploinsufficiency of cathepsin D leads to lysosomal dysfunction and promotes cell-to-cell transmission of α-synuclein aggregates
- (2015) E-J Bae et al. Cell Death & Disease
- Cerebrospinal fluid lysosomal enzymes and alpha-synuclein in Parkinson's disease
- (2014) Lucilla Parnetti et al. MOVEMENT DISORDERS
- GBA-associated Parkinson's disease: Reduced survival and more rapid progression in a prospective longitudinal study
- (2014) Kathrin Brockmann et al. MOVEMENT DISORDERS
- Factors Influencing the Measurement of Lysosomal Enzymes Activity in Human Cerebrospinal Fluid
- (2014) Emanuele Persichetti et al. PLoS One
- iPSC-derived neurons from GBA1-associated Parkinson’s disease patients show autophagic defects and impaired calcium homeostasis
- (2014) David C. Schöndorf et al. Nature Communications
- Saposin C Protects Glucocerebrosidase against α-Synuclein Inhibition
- (2013) Thai Leong Yap et al. BIOCHEMISTRY
- Functional analysis of 11 novel GBA alleles
- (2013) Erika Malini et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- First pilot newborn screening for four lysosomal storage diseases in an Italian region: Identification and analysis of a putative causative mutation in the GBA gene
- (2012) Silvia Paciotti et al. CLINICA CHIMICA ACTA
- Increased blood-cerebrospinal fluid transfer of albumin in advanced Parkinson’s disease
- (2012) Valerio Pisani et al. Journal of Neuroinflammation
- Membrane-bound α-synuclein interacts with glucocerebrosidase and inhibits enzyme activity
- (2012) Thai Leong Yap et al. MOLECULAR GENETICS AND METABOLISM
- The glucocerobrosidase E326K variant predisposes to Parkinson's disease, but does not cause Gaucher's disease
- (2012) Raquel Duran et al. MOVEMENT DISORDERS
- Meta-analysis of Parkinson's Disease: Identification of a novel locus, RIT2
- (2011) Nathan Pankratz et al. ANNALS OF NEUROLOGY
- Prosaposin sorting is mediated by oligomerization
- (2011) Libin Yuan et al. EXPERIMENTAL CELL RESEARCH
- The enigma of the E326K mutation in acid β-glucocerebrosidase
- (2011) Mia Horowitz et al. MOLECULAR GENETICS AND METABOLISM
- Characterization of the c.(-203)A>G variant in the glucocerebrosidase gene and its association with phenotype in Gaucher disease
- (2010) Pilar Alfonso et al. CLINICA CHIMICA ACTA
- Towards understanding the neuronal ceroid lipofuscinoses
- (2009) Alfried Kohlschütter et al. BRAIN & DEVELOPMENT
- Cerebrospinal fluid β-glucocerebrosidase activity is reduced in Dementia with Lewy Bodies
- (2009) L. Parnetti et al. NEUROBIOLOGY OF DISEASE
- Alterations in lysosomal and proteasomal markers in Parkinson's disease: Relationship to alpha-synuclein inclusions
- (2009) Yaping Chu et al. NEUROBIOLOGY OF DISEASE
- Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
- (2009) E. Sidransky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo
- (2009) Valerie Cullen et al. Molecular Brain
- Cathepsin D Is the Main Lysosomal Enzyme Involved in the Degradation of α-Synuclein and Generation of Its Carboxy-Terminally Truncated Species†
- (2008) Daniel Sevlever et al. BIOCHEMISTRY
- Haplotype analysis suggests a single Balkan origin for the Gaucher disease [D409H;H255Q] double mutant allele
- (2008) Raül Santamaria et al. HUMAN MUTATION
- Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicity
- (2008) Liyan Qiao et al. Molecular Brain
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search